Segall Bryant & Hamill, LLC Insulet Corp Transaction History

Segall Bryant & Hamill, LLC

$7.16 Billion
Q3 2024

A detailed history of Segall Bryant & Hamill, LLC transactions in Insulet Corp stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 63,052 shares of PODD stock, worth $16.4 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

63,052

Previous 47,369 33.11%

Holding current value

$16.4 Million

Previous $9.56 Million 53.52%

% of portfolio

0.21%

Previous 0.17%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$180.69 - $239.01 $2.83 Million - $3.75 Million	15,683 Added 33.11%	63,052 $14.7 Million
Q2 2024 Aug 14, 2024	BUY	$161.02 - $206.98 $253,123 - $325,372	1,572 Added 3.43%	47,369 $9.56 Million
Q1 2024 May 15, 2024	BUY	$163.6 - $209.11 $204,009 - $260,760	1,247 Added 2.8%	45,797 $7.85 Million
Q4 2023 Feb 14, 2024	BUY	$127.77 - $221.42 $179,261 - $310,652	1,403 Added 3.25%	44,550 $9.67 Million
Q3 2023 Nov 09, 2023	SELL	$154.67 - $290.89 $4.5 Million - $8.46 Million	-29,072 Reduced 40.26%	43,147 $6.88 Million
Q2 2023 Aug 11, 2023	BUY	$272.48 - $330.23 $137,057 - $166,105	503 Added 0.7%	72,219 $20.8 Million
Q1 2023 May 15, 2023	BUY	$276.36 - $326.03 $863,901 - $1.02 Million	3,126 Added 4.56%	71,716 $22.9 Million
Q4 2022 Feb 14, 2023	BUY	$212.22 - $313.46 $14.6 Million - $21.5 Million	68,590 New	68,590 $20.2 Million
Q3 2022 Nov 14, 2022	BUY	$224.6 - $281.45 $15.7 Million - $19.6 Million	69,764 New	69,764 $16 Million
Q2 2022 Aug 15, 2022	BUY	$186.4 - $279.02 $458,171 - $685,831	2,458 Added 4.17%	61,360 $13.4 Million
Q1 2022 May 13, 2022	BUY	$194.8 - $275.7 $1.33 Million - $1.88 Million	6,819 Added 13.09%	58,902 $15.7 Million
Q4 2021 Feb 14, 2022	SELL	$255.32 - $318.29 $2.36 Million - $2.95 Million	-9,256 Reduced 15.09%	52,083 $13.9 Million
Q3 2021 Nov 03, 2021	SELL	$260.36 - $307.27 $34,367 - $40,559	-132 Reduced 0.21%	61,339 $17.4 Million
Q2 2021 Aug 12, 2021	BUY	$225.52 - $304.06 $3.8 Million - $5.13 Million	16,857 Added 37.78%	61,471 $16.9 Million
Q1 2021 May 13, 2021	SELL	$235.95 - $293.05 $2.72 Million - $3.37 Million	-11,509 Reduced 20.51%	44,614 $11.6 Million
Q4 2020 Feb 12, 2021	BUY	$215.97 - $265.89 $626,744 - $771,612	2,902 Added 5.45%	56,123 $14.3 Million
Q3 2020 Nov 13, 2020	BUY	$192.55 - $236.59 $793,883 - $975,460	4,123 Added 8.4%	53,221 $12.6 Million
Q2 2020 Aug 14, 2020	SELL	$159.17 - $224.73 $1.15 Million - $1.62 Million	-7,215 Reduced 12.81%	49,098 $9.54 Million
Q1 2020 May 14, 2020	SELL	$130.01 - $216.44 $105,698 - $175,965	-813 Reduced 1.42%	56,313 $9.33 Million
Q4 2019 Feb 11, 2020	SELL	$144.81 - $186.0 $5.96 Million - $7.65 Million	-41,147 Reduced 41.87%	57,126 $9.78 Million
Q3 2019 Nov 12, 2019	SELL	$117.35 - $167.95 $2.83 Million - $4.05 Million	-24,128 Reduced 19.71%	98,273 $16.2 Million
Q2 2019 Aug 14, 2019	SELL	$82.13 - $120.73 $1.28 Million - $1.88 Million	-15,573 Reduced 11.29%	122,401 $0
Q1 2019 May 15, 2019	SELL	$72.44 - $101.87 $161,251 - $226,762	-2,226 Reduced 1.59%	137,974 $0
Q4 2018 Feb 15, 2019	BUY	$73.27 - $105.19 $210,577 - $302,316	2,874 Added 2.09%	140,200 $11.1 Million
Q3 2018 Nov 14, 2018	SELL	$81.43 - $108.13 $768,943 - $1.02 Million	-9,443 Reduced 6.43%	137,326 $0
Q2 2018 Aug 08, 2018	SELL	$83.27 - $101.93 $2.12 Million - $2.6 Million	-25,514 Reduced 14.81%	146,769 $0
Q1 2018 May 16, 2018	SELL	$68.49 - $87.2 $1.95 Million - $2.48 Million	-28,424 Reduced 14.16%	172,283 $0
Q4 2017 Feb 15, 2018	BUY	$55.67 - $71.8 $1.06 Million - $1.37 Million	19,105 Added 10.52%	200,707 $0
Q3 2017 Nov 14, 2017	BUY	$49.68 - $59.46 $9.02 Million - $10.8 Million	181,602	181,602 $0

Others Institutions Holding PODD

# of Institutions

685

Shares Held

62.7M

Call Options Held

640K

Put Options Held

881K

View Full List

About INSULET CORP

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

More about PODD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.

Account

Segall Bryant & Hamill, LLC Insulet Corp Transaction History